Previous work by our group underlined in preclinical models that chemotherapy could favor CD8 recruitment and activation thus enhancing efficacy of checkpoint inhibitor in preclinical model of MSS (microsatellite stability) colon tumors [10]. The gene discussed is CD8A; the disease is colonic neoplasm.